Kezar Life Sciences
KZR
KZR
50 hedge funds and large institutions have $176M invested in Kezar Life Sciences in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+11
Holders Change %
+28.21%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
16
Increased
25
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BB
1
BB Biotech
Schaffhausen,
Switzerland
|
$21.7M |
| 2 |
2
BlackRock
New York
|
$11.3M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$7.2M |
| 4 |
SC
4
Slow Capital
Greenbrae,
California
|
$3.65M |
| 5 |
FM
5
Frazier Management
Seattle,
Washington
|
$6.57M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OFM
51
Omega Fund Management
Boston,
Massachusetts
| – | -$15.9M | -67,562 | Closed |
|
|
SFM
52
Sphera Funds Management
Tel Aviv,
Israel
| – | -$472K | -2,000 | Closed |
|
53
UBS Group
Zurich,
Switzerland
| – | -$45K | -190 | Closed |
|
|
CCA
54
Catalyst Capital Advisors
Huntington,
New York
| – | -$7K | -30 | Closed |
|
55
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -7 | Closed |
|